 |
||||||||
 |
 |
 |
 |
 |
||||
Flavio Grynszpan, Ph.D., Director of R&D, joined Salio on 2007. Flavio received his scientific education at the Hebrew University of Jerusalem (Israel), where he earned his Ph.D. working on chemical modifications and conformational analysis of calixarenes in 1995. Dr. Grynszpan performed his postdoctoral research on catalytic antibodies at The Scripps Research Institute where he later held a tenure track position of Assistant Professor for about five years. Among other Awards and Honors, Flavio was named Fellow of the John Simon Guggenheim Foundation, during his tenure at Scripps. From 2002 Dr. Grynszpan served as the Head of Innovative Medicinal Chemistry at Compugen (NASDAQ: CGEN). From 2004 Dr. Grynszpan acted as Associate Director of Chemistry at Pharmos (NASDAQ: PARS). Flavio co-authored more than 30 scientific peer reviewed papers and presented over 30 research lectures and papers in scientific international meetings.
Scientific Advisory Board:
Prof. Jay Siegel, Professor and co-director of the Organic chemistry institute of the University of Zurich and Director of its laboratory for process chemistry research (LPF). Prof. Siegel earned his Ph.D. in Princeton (1985) and became an full time Professor at UCSD. He was named a US-NSF Presidential Young Investigator in 1988, an American Cancer Society Jr. Fellow in 1990, an Alfred P. Sloan Fellow in 1992, and an Arthur C. Cope Scholar by the ACS in 1998. He was elected fellow of the American Association for the Advancement of Science in 1998. He has been visiting professor at Princeton, Caltech, University of Basel, the Weizmann Institute and Tokyo Institute of Technology. He has published over 130 papers, edited 4 book/journal special volumes, is co-Editor in Chief of Topics in Stereochemistry and is on the editorial advisory board of Organic and Biomolecular Chemistry, Eur-JOC, and J. Phys Org. Chem. He has presented over 250 international research lectures. From his research group have emerged roughly 50 research chemists, 13 of who are Professors worldwide, 2 head their own companies. His research interests focus on the synthesis and stereochemistry of designed molecular architectures.
Artem Melman, Ph.D. received his Ph.D. in Organic Chemistry from the Weizmann Institute of Science, Israel in 1997. After two years of postdoctoral studies at the University of Oxford he worked as Lecturer at the Hebrew University of Jerusalem. His main research interest involve total synthesis of biologically active natural compounds, development of new synthetic methodologies, medicinal chemistry, coordination chemistry of transition metals, and studies of self-assembled molecular systems. Artem published more that thirty scientific papers and seven patents.
Prof. Avigdor Scherz, Inventor, is a Professor at the Department of Plant Sciences at the Weizmann Institute and Head of the Minerva-Avron Center for Photosynthesis. His interest includes (i) photodynamic therapy, (ii) rational design, synthesis and application of new PDT reagents, (iii) physicochemical aspects of photosynthesis and biological redox reactions, (iv) photobiology, and (v) chlorophyll chemistry and spectroscopy. His group developed a novel method for quantification of sub-molecular level interactions between groups and molecules using customized chromophores. He was a visiting scholar at the University of Chicago and a visiting professor at the University of Tokyo. A.S. holds the Robert and Yadelle professorial chair in Biochemistry.
Roie Yerushalmi, Ph.D. Inventor, , received his Ph.D. from the Weizmann Institute of Science, Israel in 2005. His studies with Professor Avigdor Scherz focused on the design molecular systems for monitoring charge transfer between interacting chemical entities in solution and at interfaces. His research interests relate to molecular design of thin films, model systems of enzymatic reactions, coordination chemistry, and the application quantum mechanical methods. He is continuing his research as a post-doctoral fellow at UC Berkeley.